Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
- 1 October 2000
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 7 (19), 1613-1623
- https://doi.org/10.1038/sj.gt.3301292
Abstract
We describe the generation and the characterization of new lentiviral vectors derived from SIVmac251, a simian immunodeficiency virus (SIV). A methodical approach was used to engineer both efficient and safe packaging constructs allowing the production of SIV viral core proteins. SIV-vectors encoding GFP (green fluorescent protein) were generated as VSV-G-pseudotyped particles upon transient expression of the vector construct and helper functions in 293 cells. The SIV vectors were able to transduce efficiently various target cell types at low multiplicity of infection, including monocyte-differentiated human dendritic cells (DCs) which retained their capacity to differentiate into mature DCs after gene transfer. Transduction of the DCs by the SIV vectors was prevented when infections were performed in the presence of AZT, a reverse-transcriptase inhibitor. After gene transfer, expression of the GFP in the target cells remained constant after several weeks, indicating that the vectors had been stably integrated into the genome of the host cells. Preparations of SIV vectors were systematically checked for the absence of replication-competent and recombinant retroviruses but remained negative, suggesting the innocuousness of these novel gene delivery vectors. Side-to-side comparisons with vectors derived from HIV-1 (human immunodeficiency virus) indicated that the SIV vectors were equally potent in transducing proliferating target cells. Finally, we have determined the infectivity of SIV vectors pseudotyped with surface glycoproteins of several membrane-enveloped viruses.Keywords
This publication has 38 references indexed in Scilit:
- Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivoGene Therapy, 2000
- Development of a Self-Inactivating, Minimal Lentivirus Vector Based on Simian Immunodeficiency VirusHuman Gene Therapy, 2000
- Stable gene transfer to the nervous system using a non-primate lentiviral vectorGene Therapy, 1999
- Lentivirus-Mediated Transduction of Islet Grafts with Interleukin 4 Results in Sustained Gene Expression and Protection from InsulitisHuman Gene Therapy, 1998
- Retrovirus-Mediated Gene Transfer into Human CD34+38lowPrimitive Cells Capable of Reconstituting Long-Term CulturesIn Vitroand Nonobese Diabetic–Severe Combined Immunodeficiency MiceIn VivoHuman Gene Therapy, 1998
- Human Immunodeficiency Virus Type 2 Lentivirus Vectors for Gene Transfer: Expression and Potential for Helper Virus-Free PackagingHuman Gene Therapy, 1998
- High-Level Gene Transfer to Cord Blood Progenitors Using Gibbon Ape Leukemia Virus Pseudotype Retroviral Vectors and an Improved Clinically Applicable ProtocolHuman Gene Therapy, 1998
- Highly Efficient Retrovirus-Mediated Gene Transfer into Rat HepatocytesIn VivoHuman Gene Therapy, 1997
- Establishment of Parameters for Optimal Transduction Efficiency and Antitumor Effects with Purified High-Titer HSV-TK Retroviral Vector in Established Solid TumorsHuman Gene Therapy, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996